Matejuk, Agata
Benedek, Gil
Bucala, Richard
Matejuk, Szymon
Offner, Halina
Vandenbark, Arthur A.
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR078334)
Rheumatology Research Foundation
G. Harold and Leila Y. Mathers Charitable Foundation
National Institute of Allergy and Infectious Diseases (AI148409, AI122574)
Biomedical Laboratory Research and Development, VA Office of Research and Development (BX000226)
Article History
Received: 3 July 2023
Accepted: 12 December 2023
First Online: 4 January 2024
Declarations
:
: Not applicable.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Drs. Vandenbark and Offner, and OHSU, have a significant financial interest in Artielle ImmunoTherapeutics, Inc., a company that may have a commercial interest in the results of this research and technology. This potential conflict of interest has been reviewed and managed by the OHSU and VA Portland Health Care System Conflict of Interest in Research Committees.